Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil
Information source: University of Edinburgh
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Shoulder Dislocation
Intervention: Sedation with propofol and remifentanil (Drug)
Phase: N/A
Status: Terminated
Sponsored by: University of Edinburgh Official(s) and/or principal investigator(s): Gordon B Drummond, FRCA, Principal Investigator, Affiliation: University of Edinburgh
Summary
For reduction of dislocated shoulder, sedation with propofol and remifentanil should give
satisfactory operating conditions and pain relief, and significantly reduce the time to full
recovery, compared with morphine and midazolam
Clinical Details
Official title: Comparison of Sedation/Analgesia: Midazolam/Morphine Vs Propofol/Remifentanil
Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary outcome: Time to full recovery
Secondary outcome: Operating conditionsPain or discomfort
Detailed description:
Propofol is a recognised agent for sedation and remifentanil is a short acting opioid
analgesic. We intend to provide sedation with propofol, 0. 5 mg/Kg, and analgesia with
remifentanil 0. 5 microgram/Kg for reduction of dislocated shoulders. This will be a
randomised sex-stratified comparison with current therapy which is midazolam incrementally up
to a maximum of 0. 15 mg/Kg, and morphine incrementally up to 0. 15 mg/Kg. The primary outcome
measure is time to full recovery. Secondary aspects are pain or discomfort during the
procedure and operating conditions.
Eligibility
Minimum age: 16 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Anterior dislocation of the shoulder suitable for manual reduction
Exclusion Criteria:
- significant other illness
- body weight 25% greater than expected
- fear of oxygen masks
- alcohol intoxication
Locations and Contacts
Royal Infirmary, Edinburgh, Midlothian EH16 4HA, United Kingdom
Additional Information
Related publications: Dunn MJ, Mitchell R, Souza CD, Drummond G. Evaluation of propofol and remifentanil for intravenous sedation for reducing shoulder dislocations in the emergency department. Emerg Med J. 2006 Jan;23(1):57-8.
Starting date: July 2003
Ending date: June 2005
Last updated: May 15, 2006
|